Advertisement

The impact of metabolic syndrome on 30-day outcomes in geriatric hip fracture surgeries

  • Azeem Tariq Malik
  • Carmen E. Quatman
  • Laura S. Phieffer
  • Thuan V. Ly
  • Jessica Wiseman
  • Safdar N. KhanEmail author
Original Article • HIP - FRACTURES
  • 99 Downloads

Abstract

Purpose

Past literature has reported metabolic syndrome (MetS) to complicate postoperative care in patients undergoing various surgical procedures. We sought to analyze the impact of MetS on 30-day outcomes following hip fracture surgeries in the geriatric population.

Materials and methods

The 2015–2016 ACS-NSQIP database was queried for patients undergoing hip fracture repair using CPT codes for total hip arthroplasty (27130), hemiarthroplasty (27125) and open reduction internal fixation (27236, 27244, 27245). Only patients ≥ 65 years of age undergoing surgery due to a traumatic hip fracture were included in the study. MetS was defined using preset criteria used by other NSQIP studies as the presence of—(1) diabetes mellitus AND (2) hypertension requiring medication AND (3) BMI ≥ 30 kg/m2.

Results

Out of 31,621 patients, a total of 1388 (4.4%) geriatric patients with MetS underwent hip fracture surgery. Following adjusted analysis, the presence of MetS was associated with higher odds of a prolonged length of stay > 5 days (OR 1.14 [95% CI 1.01–1.29]; p = 0.031), deep SSI (OR 2.48 [95% CI 1.20–5.14]; p = 0.014), progressive renal insufficiency (OR 3.27 [95% CI 1.98–5.42]; p < 0.001), acute renal failure (OR 2.08 [95% CI 1.04–4.15]; p = 0.038), urinary tract infection (OR 1.43 [95% CI 1.12–1.81]; p = 0.004), 30-day readmissions (OR 1.28 [95% CI 1.08–1.52]; p = 0.005) and a non-home discharge (OR 1.42 [95% CI 1.18–1.71]; p < 0.001).

Conclusion

MetS is associated with a significantly increased risk of several postoperative complications, readmissions and non-home discharge dispositions. Providers can utilize these data to promote the need for better perioperative care in these high-risk patients.

Keywords

Metabolic syndrome Hip fracture Geriatric Surgery Repair Outcomes NSQIP MetS Complications Readmissions 

Notes

Acknowledgements

None.

Compliance with ethical standards

Conflict of interest

Authors Safdar N. Khan and Thuan Ly have received research grants from Spinal Kinetics.

Disclosures

The American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS-NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.

References

  1. 1.
    Kaur J (2014) A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162.  https://doi.org/10.1155/2014/943162 Google Scholar
  2. 2.
    Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefGoogle Scholar
  3. 3.
    Chung AS, Campbell D, Waldrop R, Crandall D (2018) Metabolic syndrome and 30-day outcomes in elective lumbar spinal fusion. Spine (Phila Pa 1976) 43(9):661–666.  https://doi.org/10.1097/brs.0000000000002397 CrossRefGoogle Scholar
  4. 4.
    Tee MC, Ubl DS, Habermann EB, Nagorney DM, Kendrick ML, Sarr MG, Truty MJ, Que FG, Reid-Lombardo K, Smoot RL, Farnell MB (2016) Metabolic syndrome is associated with increased postoperative morbidity and hospital resource utilization in patients undergoing elective pancreatectomy. J Gastrointest Surg 20(1):189–198.  https://doi.org/10.1007/s11605-015-3007-9 (discussion 198) CrossRefGoogle Scholar
  5. 5.
    Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose K, Edil B, Herman JM, Choti MA, Pawlik TM (2012) Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 152(2):218–226.  https://doi.org/10.1016/j.surg.2012.05.037 CrossRefGoogle Scholar
  6. 6.
    Edelstein AI, Lovecchio F, Delagrammaticas DE, Fitz DW, Hardt KD, Manning DW (2017) The impact of metabolic syndrome on 30-day complications following total joint arthroplasty. J Arthroplasty 32(2):362–366.  https://doi.org/10.1016/j.arth.2016.08.007 CrossRefGoogle Scholar
  7. 7.
    Menendez ME, Neuhaus V, Bot AG, Ring D, Johnson AH (2014) The impact of metabolic syndrome on inpatient outcomes after isolated ankle fractures. Foot Ankle Int 35(5):463–470.  https://doi.org/10.1177/1071100714524555 CrossRefGoogle Scholar
  8. 8.
    Zhou J, Zhang Q, Yuan X, Wang J, Li C, Sheng H, Qu S, Li H (2013) Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone 57(1):30–35.  https://doi.org/10.1016/j.bone.2013.07.013 CrossRefGoogle Scholar
  9. 9.
    Huang CS, Cheu YD, Ying J, Wei MH (2011) Association between provider volume and comorbidity on hospital utilization and outcomes of total hip arthroplasty among National Health Insurance enrollees. J Formos Med Assoc 110(6):401–409.  https://doi.org/10.1016/S0929-6646(11)60059-4 CrossRefGoogle Scholar
  10. 10.
    Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, Lee SH, Koh JM, Han KO, Park HM, Kim GS (2010) Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int 86(5):350–358.  https://doi.org/10.1007/s00223-010-9347-2 CrossRefGoogle Scholar
  11. 11.
    Yaturu S, Humphrey S, Landry C, Jain SK (2009) Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit 15(1):CR5–9Google Scholar
  12. 12.
    von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E (2007) Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 18(10):1337–1344.  https://doi.org/10.1007/s00198-007-0385-1 CrossRefGoogle Scholar
  13. 13.
    Wang D, Liu N, Gao Y, Li P, Tian M (2014) Association between metabolic syndrome and osteoporotic fracture in middle-aged and elderly Chinese peoples. Cell Biochem Biophys 70(2):1297–1303.  https://doi.org/10.1007/s12013-014-0054-x CrossRefGoogle Scholar
  14. 14.
    Hwang DK, Choi HJ (2010) The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int 21(3):425–431.  https://doi.org/10.1007/s00198-009-0990-2 CrossRefGoogle Scholar
  15. 15.
    McFarlane SI (2006) Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights. J Cardiometab Syndr 1(1):53–57CrossRefGoogle Scholar
  16. 16.
    Loke SS, Chang HW, Li WC (2018) Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population. J Bone Miner Metab 36(2):200–208.  https://doi.org/10.1007/s00774-017-0826-7 CrossRefGoogle Scholar
  17. 17.
    Mosca LN, Goldberg TB, da Silva VN, da Silva CC, Kurokawa CS, Bisi Rizzo AC, Corrente JE (2014) Excess body fat negatively affects bone mass in adolescents. Nutrition 30(7–8):847–852.  https://doi.org/10.1016/j.nut.2013.12.003 CrossRefGoogle Scholar
  18. 18.
    Bilic-Curcic I, Makarovic S, Mihaljevic I, Franceschi M, Jukic T (2017) Bone mineral density in relation to metabolic syndrome components in postmenopausal women with diabetes mellitus type 2. Acta Clin Croat 56(1):58–63.  https://doi.org/10.20471/acc.2017.56.01.09 CrossRefGoogle Scholar
  19. 19.
    Jeon YK, Lee JG, Kim SS, Kim BH, Kim SJ, Kim YK, Kim IJ (2011) Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J 58(2):87–93CrossRefGoogle Scholar
  20. 20.
    Timar O, Sestier F, Levy E (2000) Metabolic syndrome X: a review. Can J Cardiol 16(6):779–789Google Scholar
  21. 21.
    Memtsoudis SG, Kirksey M, Ma Y, Chiu YL, Mazumdar M, Pumberger M, Girardi FP (2012) Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine (Phila Pa 1976) 37(11):989–995.  https://doi.org/10.1097/brs.0b013e31823a3a13 CrossRefGoogle Scholar
  22. 22.
    Murphy AB, Menendez ME, Watson SL, Ponce BA (2016) Metabolic syndrome and shoulder arthroplasty: epidemiology and peri-operative outcomes. Int Orthop 40(9):1927–1933.  https://doi.org/10.1007/s00264-016-3214-3 CrossRefGoogle Scholar
  23. 23.
    Gonzalez Della Valle A, Chiu YL, Ma Y, Mazumdar M, Memtsoudis SG (2012) The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty 27(10):1743–1749 e1741.  https://doi.org/10.1016/j.arth.2012.04.011 CrossRefGoogle Scholar
  24. 24.
    Pierce A, Pittet JF (2014) Inflammatory response to trauma: implications for coagulation and resuscitation. Curr Opin Anaesthesiol 27(2):246–252.  https://doi.org/10.1097/ACO.0000000000000047 CrossRefGoogle Scholar
  25. 25.
    Bohl DD, Ondeck NT, Basques BA, Levine BR, Grauer JN (2017) What is the timing of general health adverse events that occur after total joint arthroplasty? Clin Orthop Relat Res 475(12):2952–2959.  https://doi.org/10.1007/s11999-016-5224-2 CrossRefGoogle Scholar
  26. 26.
    Garcia GH, Fu MC, Webb ML, Dines DM, Craig EV, Gulotta LV (2016) Effect of metabolic syndrome and obesity on complications after shoulder arthroplasty. Orthopedics 39(5):309–316.  https://doi.org/10.3928/01477447-20160517-03 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France SAS, part of Springer Nature 2018

Authors and Affiliations

  • Azeem Tariq Malik
    • 1
  • Carmen E. Quatman
    • 1
  • Laura S. Phieffer
    • 1
  • Thuan V. Ly
    • 1
  • Jessica Wiseman
    • 1
  • Safdar N. Khan
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of OrthopaedicsThe Ohio State University Wexner Medical CenterColumbusUSA
  2. 2.The Benjamin R. and Helen Slack Wiltberger Endowed Chair in Orthopaedic Spine SurgeryWexner Medical Center at The Ohio State UniversityColumbusUSA
  3. 3.Department of Integrated Systems Engineering, Clinical Faculty, Spine Research InstituteWexner Medical Center at The Ohio State UniversityColumbusUSA

Personalised recommendations